Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Pinder

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|March 4, 2000
Gamma linolenic acid with tamoxifen as primary therapy in breast cancerF S Kenny, S E Pinder, I O Ellis, et al.
The Journal of Pathology|May 20, 2003
Prognostic significance of BRCA1 expression in sporadic breast carcinomasH Lambie, A Miremadi, S E Pinder, et al.
Clinical Radiology|April 1, 1996
The positive predictive value of mammographic signs: a review of 425 non-palpable breast lesionsH C Burrell, S E Pinder, A R Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2007
Reading the prognosis of the individual with breast cancerR W Blamey, S E Pinder, G R Ball, et al.
Clinical Radiology|May 19, 2018
NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)S E Pinder, A Shaaban, R Deb, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 29, 2003
Spindle cell carcinoma of the breast: a case series of a rare histological subtypeH N Khan, L Wyld, B Dunne, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2000
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreementL W Dalton, S E Pinder, C E Elston, et al.
Clinical Radiology|August 1, 1994
Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast TeamA J Evans, S E Pinder, I O Ellis, et al.
Breast (Edinburgh, Scotland)|June 4, 2013
Patterns of metastatic spread in early breast cancerM B Klevesath, K Pantel, O Agbaje, et al.
Journal of Clinical Pathology|April 3, 2008
HER2 testing in the UK: further update to recommendationsR A Walker, J M S Bartlett, M Dowsett, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|March 4, 2000
Gamma linolenic acid with tamoxifen as primary therapy in breast cancerF S Kenny, S E Pinder, I O Ellis, et al.
The Journal of Pathology|May 20, 2003
Prognostic significance of BRCA1 expression in sporadic breast carcinomasH Lambie, A Miremadi, S E Pinder, et al.
Clinical Radiology|April 1, 1996
The positive predictive value of mammographic signs: a review of 425 non-palpable breast lesionsH C Burrell, S E Pinder, A R Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2007
Reading the prognosis of the individual with breast cancerR W Blamey, S E Pinder, G R Ball, et al.
Clinical Radiology|May 19, 2018
NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)S E Pinder, A Shaaban, R Deb, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 29, 2003
Spindle cell carcinoma of the breast: a case series of a rare histological subtypeH N Khan, L Wyld, B Dunne, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2000
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreementL W Dalton, S E Pinder, C E Elston, et al.
Clinical Radiology|August 1, 1994
Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast TeamA J Evans, S E Pinder, I O Ellis, et al.
Breast (Edinburgh, Scotland)|June 4, 2013
Patterns of metastatic spread in early breast cancerM B Klevesath, K Pantel, O Agbaje, et al.
Journal of Clinical Pathology|April 3, 2008
HER2 testing in the UK: further update to recommendationsR A Walker, J M S Bartlett, M Dowsett, et al.
Pageof 15